Corporate Officers
 

Richard J. Freer, Ph.D.
Chairman of the Board
and COO
Since founding Commonwealth Biotechnologies, Inc., in 1992 with three other partners,  Dr. Freer has served as Chairman of the Board and as a Director of the Company. From 1975 until 1997, Dr. Freer was employed in the Department of Pharmacology and Toxicology at Virginia Commonwealth University, rising through the academic ranks to full Professor. In addition, from 1988-1995, Dr. Freer was first Director and then Chair of the Biomedical Engineering Program. Freer received the Bachelor's degree in Biology/Chemistry from Marist College, Poughkeepsie, NY, and the Doctoral degree from Columbia University in Pharmacology. Dr. Freer is the co-author of more than 150 peer reviewed journal articles and book chapters, in his area of research expertise, molecular pharmacology, peptide receptors, and is a co-inventor of 2 US patents.  Dr. Freer is a former Established Investigator of the American Heart Association and a National Institutes of Health Fogarty Senior International Fellow.
 
Robert B. Harris, Ph.D.
President & CEO

Since founding Commonwealth Biotechnologies, Inc., in 1992 with three other partners, Dr. Harris has served as the President and as a Director of the Company. Until 1997, Dr. Harris was employed in the Department of Biochemistry and Molecular Biophysics at Virginia Commonwealth University, rising through the academic ranks to full Professor. Dr. Harris received a joint Bachelor's degree in Chemistry and Biology from the University of Rochester, Rochester, NY, and the Master's and Doctoral degrees from New York University, in Biochemistry and Biophysical Chemistry. Dr. Harris is the co-author of more than 75 peer reviewed journal articles and book chapters, mostly in areas of his research expertise: the role of macromolecular structure in biological function. Dr. Harris is a former Established Investigator of the American Heart Association, and is co-inventor of US and PCT patents.

Thomas R. Reynolds, B.S.
Executive Vice President, Science & Technology
and Secretary
Since founding Commonwealth Biotechnologies, Inc., in 1992 with three other partners, Mr. Reynolds has served as Vice President, Senior Vice President and Executive Vice President as well as a Director of the Company. Mr. Reynolds became Secretary of the Board of Directors in 1998. Mr. Reynolds is responsible for oversight of all DNA related technologies and services including management oversight of the Fairfax Identity Laboratory division. From 1987 until 1997, Mr. Reynolds served as Manager of the Nucleic Acids Core Laboratory at The Massey Cancer Center in the Department of Microbiology Biology and Immunology at Virginia Commonwealth University. From 1984 through 1986, Reynolds served as a research assistant in Genetics at Carnegie Mellon University. Mr. Reynolds is a co-inventor of several US patents, and co-author of more than 35 peer reviewed journal articles and book chapters, in the research area of molecular genetics.

James H. Brennan, M.B.A. 
Mr. Brennan joined the Company in December, 1997, and assumed the duties of Controller. Brennan is an Officer of the Company. From 1988- 1997, Brennan served as the Chief Financial Officer or Controller of different companies in and around the Richmond Area, including Star Tobacco and Pharmaceuticals, Delta Airport Consultants, Herald Pharmaceuticals, and the Christian Childrens' Fund.

 
Commonwealth Biotechnologies, Inc.
601 Biotech Drive, Richmond, VA 23235
800-735-9224 (800-RELY-CBI) FAX: 804-648-2641
email: [email protected]